Testosterone 200 mg/Anastrozole 20 mg pellet recalled over sterility concerns

Recall date

October 17, 2018

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Qualgen, LLC recalls Testosterone 200 mg/Anastrozole 20 mg pellet, 1 count (NDC 69761-222-01), 6 count (NDC 69761-222-06), 12 count (NDC 697…

Recall number

D-0238-2019

FDA classification

Class II

Brand / firm

Qualgen, LLC

Sold / distributed

Nationwide.

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Testosterone 200 mg/Anastrozole 20 mg pellet, 1 count (NDC 69761-222-01), 6 count (NDC 69761-222-06), 12 count (NDC 69761-222-12), and 30 count (NDC 69761-222-30) vials, Rx Only, Qualgen, Edmond, OK 73013